XML 98 R67.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Numerator:    
Net income attributable to Biogen Inc. $ 410.2 $ 1,399.1
Weighted-average shares used in calculating:    
Weighted average number of common shares outstanding 151.9 172.8
Effect of dilutive securities:    
Dilutive potential common shares 0.4 0.3
Shares used in calculating diluted earnings per share 152.3 173.1
Time-vested restricted stock units    
Effect of dilutive securities:    
Stock units 0.2 0.1
Market stock units    
Effect of dilutive securities:    
Stock units 0.1 0.1
Performance stock units settled in stock    
Effect of dilutive securities:    
Stock units 0.1 0.1